Lessons learned from Restoring Study 329: Transparent reporting, open databases and network meta-analyses as the way forward

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 4, 2017, Pages 407-409

  Barber, Sarah ^a   Cipriani, Andrea ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; PAROXETINE; PLACEBO;

ANONYMISED DATA; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MAJOR DEPRESSION; PRACTICE GUIDELINE; PUBLICATION; STUDY DESIGN; FACTUAL DATABASE; NETWORK META-ANALYSIS; PUBLISHING;

DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; HUMANS; NETWORK META-ANALYSIS; PUBLISHING;

EID: 85018262451     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867416676372     Document Type: Letter

References (5)

1. Cipriani A, Zhou X, Del Giovane C, et al. (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. Lancet 388: 881-890.
2. Goldacre B, (2016) Make journals report clinical trials properly. Nature 530: 7.
3. Le Noury J, Nardo JM, Healy D, et al. (2015) Restoring Study 329: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351: h4320.
4. Mavridis D, Giannatsi M, Cipriani A, et al. (2015) A primer on network meta-analysis with emphasis on mental health. Evidence-Based Mental Health 18: 40-46.
5. Mulder R, Rucklidge JJ, Toop L, (2016) Restoring Study 329: Paroxetine neither effective nor safe for adolescents. Australian and New Zealand Journal of Psychiatry 50: 922-923.